Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
MONASHEES
São PauloPre-Seed–Growth$10M
31 people
DBAG
Frankfurt am MainGrowth
64 people
Sagard Private Equity Canada
Toronto, OntarioGrowth
79 people
HLM Investment Partners
WalthamSeries A–Growth$3M – $5M
35 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiSeed–Late Stage$5.4M – $16.2M
24 people
TriplePoint Capital
Menlo ParkSeed–Late Stage
67 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage
27 people
Axcel Management A/S
CopenhagenGrowth
68 people
BOM
TilburgSeed–Growth$540K – $5.8M
17 people
Lightyear
New YorkGrowth
62 people
Cambridge Innovation Capital
CambridgeSeed–Growth$127K – $12.7M
57 people
Atlantic Vantage Point
ParisSeed–Growth$1M – $150M
47 people
Artesian
SydneyPre-Seed–Growth$20M
41 people
Genesia Ventures
TokyoPre-Seed–Growth
16 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
BayPine
BostonGrowth–Late Stage
74 people
Advent International
BostonGrowth–Late Stage$1.1B
58 people
Hummingbird Ventures
BrusselsPre-Seed–Growth$500K – $10M
40 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
51 people
UntroD Capital
TokyoSeed–Growth
38 people
Navis Capital Partners
Kuala LumpurGrowth–Late Stage$30M – $500M
38 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Bowmark Capital
LondonGrowth$13M – $260M
56 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.
















































































































